Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.627 USD | -2.03% | +12.73% | +19.99% |
09/05 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
01/04 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.99% | 7.71Cr | |
+7.11% | 11TCr | |
+11.05% | 11TCr | |
+0.76% | 2.23TCr | |
-12.42% | 2.22TCr | |
-5.20% | 1.94TCr | |
-37.85% | 1.79TCr | |
-6.18% | 1.72TCr | |
+7.73% | 1.43TCr | |
+34.88% | 1.25TCr |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- JPMorgan Downgrades Atara Biotherapeutics to Neutral From Overweight; Price Target is $10